Dana Farber Gets $33M in Sanofi Deal

Xconomy Boston — 

Sanofi-Aventis, the French drug giant that has labs in Cambridge, MA, said today that it paid Dana Farber Cancer Institute of Boston $33 million to license technology for identifying cancer targets for new treatments. Dana Farber will also receive research funding from Sanofi for a minimum of three years, as well as potential payments related to the development of drugs that result from the agreement. In July, Sanofi revealed that it planned to house a new cancer research division in Cambridge and invest $65 million in expanding its operations there.